| Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease SJ Ott, NE El Mokhtari, M Musfeldt, S Hellmig, S Freitag, A Rehman, ... Circulation 113 (7), 929-937, 2006 | 459 | 2006 |
| Colonic microbiota signatures across five northern European countries C Lay, L Rigottier-Gois, K Holmstrøm, M Rajilic, EE Vaughan, WM de Vos, ... Applied and environmental microbiology 71 (7), 4153-4155, 2005 | 343 | 2005 |
| Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? E Kaschina, A Grzesiak, J Li, A Foryst-Ludwig, M Timm, F Rompe, ... Circulation 118 (24), 2523-2532, 2008 | 318 | 2008 |
| Impact of cereal fibre on glucose-regulating factors MO Weickert, M Mohlig, C Koebnick, JJ Holst, P Namsolleck, M Ristow, ... Diabetologia 48, 2343-2353, 2005 | 252 | 2005 |
| The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke C Thöne-Reineke, C Neumann, P Namsolleck, K Schmerbach, M Krikov, ... Journal of hypertension 26 (12), 2426-2435, 2008 | 133 | 2008 |
| The past, present and future of angiotensin II type 2 receptor stimulation UM Steckelings, F Rompe, E Kaschina, P Namsolleck, A Grzesiak, ... Journal of the Renin-Angiotensin-Aldosterone System 11 (1), 67-73, 2010 | 126 | 2010 |
| Non-peptide AT2-receptor agonists UM Steckelings, M Larhed, A Hallberg, RE Widdop, ES Jones, ... Current opinion in pharmacology 11 (2), 187-192, 2011 | 124 | 2011 |
| AT2 Receptor and Tissue Injury: Therapeutic Implications P Namsolleck, C Recarti, S Foulquier, UM Steckelings, T Unger Current hypertension reports 16, 1-10, 2014 | 121 | 2014 |
| AT2 receptors in cardiovascular and renal diseases E Kaschina, P Namsolleck, T Unger Pharmacological research 125, 39-47, 2017 | 116 | 2017 |
| AT2 receptor agonists: hypertension and beyond UM Steckelings, L Paulis, P Namsolleck, T Unger Current opinion in nephrology and hypertension 21 (2), 142-146, 2012 | 110 | 2012 |
| Evidence for heterodimerization and functional interaction of the angiotensin type 2 receptor and the receptor MAS J Leonhardt, DC Villela, A Teichmann, LM Münter, MC Mayer, M Mardahl, ... Hypertension 69 (6), 1128-1135, 2017 | 109 | 2017 |
| AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression P Namsolleck, F Boato, K Schwengel, L Paulis, KS Matho, N Geurts, ... Neurobiology of disease 51, 177-191, 2013 | 92 | 2013 |
| Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis R Winkler, V Benz, M Clemenz, M Bloch, A Foryst-Ludwig, S Wardat, ... Diabetes 61 (2), 513-523, 2012 | 86 | 2012 |
| Aldosterone synthase inhibitors in cardiovascular and renal diseases P Namsolleck, T Unger Nephrology Dialysis Transplantation 29 (suppl_1), i62-i68, 2014 | 60 | 2014 |
| Molecular methods for the analysis of gut microbiota P Namsolleck, R Thiel, P Lawson, K Holmstrøm, M Rajilic, EE Vaughan, ... Microbial ecology in health and disease 16 (2-3), 71-85, 2004 | 53 | 2004 |
| Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice K Schwengel, P Namsolleck, K Lucht, BH Clausen, KL Lambertsen, ... Journal of Molecular Medicine 94, 957-966, 2016 | 50 | 2016 |
| Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune … V Valero-Esquitino, K Lucht, P Namsolleck, F Monnet-Tschudi, T Stubbe, ... Clinical science 128 (2), 95-109, 2015 | 45 | 2015 |
| Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice S Foulquier, P Namsolleck, BT Van Hagen, I Milanova, MJ Post, ... Hypertension Research 41 (10), 817-827, 2018 | 44 | 2018 |
| Clostridium asparagiforme sp. nov., isolated from a human faecal sample R Mohan, P Namsolleck, PA Lawson, M Osterhoff, MD Collins, CA Alpert, ... Systematic and applied microbiology 29 (4), 292-299, 2006 | 40 | 2006 |
| Combined angiotensin receptor modulation in the management of cardio-metabolic disorders L Paulis, S Foulquier, P Namsolleck, C Recarti, UM Steckelings, T Unger Drugs 76, 1-12, 2016 | 37 | 2016 |
